Cargando…
Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405291/ https://www.ncbi.nlm.nih.gov/pubmed/32666636 http://dx.doi.org/10.1002/cac2.12077 |
| _version_ | 1783567230671257600 |
|---|---|
| author | Wu, Qiuji Chu, Qian Zhang, Hongyan Yang, Bin He, Xudong Zhong, Yahua Yuan, Xianglin Chua, Melvin L.K. Xie, Conghua |
| author_facet | Wu, Qiuji Chu, Qian Zhang, Hongyan Yang, Bin He, Xudong Zhong, Yahua Yuan, Xianglin Chua, Melvin L.K. Xie, Conghua |
| author_sort | Wu, Qiuji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7405291 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74052912020-08-05 Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors Wu, Qiuji Chu, Qian Zhang, Hongyan Yang, Bin He, Xudong Zhong, Yahua Yuan, Xianglin Chua, Melvin L.K. Xie, Conghua Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2020-07-15 /pmc/articles/PMC7405291/ /pubmed/32666636 http://dx.doi.org/10.1002/cac2.12077 Text en © 2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Wu, Qiuji Chu, Qian Zhang, Hongyan Yang, Bin He, Xudong Zhong, Yahua Yuan, Xianglin Chua, Melvin L.K. Xie, Conghua Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| title | Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| title_full | Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| title_fullStr | Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| title_full_unstemmed | Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| title_short | Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| title_sort | clinical outcomes of coronavirus disease 2019 (covid‐19) in cancer patients with prior exposure to immune checkpoint inhibitors |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405291/ https://www.ncbi.nlm.nih.gov/pubmed/32666636 http://dx.doi.org/10.1002/cac2.12077 |
| work_keys_str_mv | AT wuqiuji clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT chuqian clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT zhanghongyan clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT yangbin clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT hexudong clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT zhongyahua clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT yuanxianglin clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT chuamelvinlk clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors AT xieconghua clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors |